Prevalence of Hepatitis E Virus Antibodies, Israel, 2009–2010

Prevalence of Hepatitis E Virus Antibodies, Israel, 2009–2010

We investigated prevalence of hepatitis E virus in a sample of the population of Israel. The overall seroprevalence of antibodies to the virus was 10.6% (95% CI 8.4%–13.0%); age-adjusted prevalence was 7.6%. Seropositivity was associated with age, Arab ethnicity, low socioeconomic status, and birth...

Full description

Bibliographic Details
Main Authors: Orna Mor, Ravit Bassal, Michal Michaeli, Marina Wax, Daniela Ram, Oranit Cohen-Ezra, Dani Cohen, Ella Mendelson, Ziv Ben-Ari, Tamy Shohat
Format: Article
Language:English
Published: Centers for Disease Control and Prevention 2015-04-01
Series:Emerging Infectious Diseases
Subjects:
Anti-HEV
hepatitis E
viruses
antibodies
IgG
Israel
Online Access:https://wwwnc.cdc.gov/eid/article/21/4/14-0245_article

Internet

https://wwwnc.cdc.gov/eid/article/21/4/14-0245_article

Similar Items